Dr. Wulff’s research is focused on potassium channel pharmacology and the design of new ion channel modulating drugs and tool compounds. She has authored 160 peer-reviewed publications on voltage- and Ca2+-activated K+ channels and was ranked in the top 1% of highly cited researchers in her field in the 2018 Clarivate Analysis.
People - Core A
Bogdan Barnych is an Assistant Project Scientist in Bruce Hammock laboratory at the University of California Davis. He has over 15 years of interdisciplinary research experience. His research as part of the CounterACT project involves development of novel sensitive analytical techniques for the detection of convulsants as well as synthesis of lipid mediators and enzyme inhibitors for mechanistic studies and drug development.
Dr. Hammock, Distinguished Professor of Entomology, UC Davis College of Agricultural and Environmental Sciences, is a toxicologist and bioorganic chemist with extensive experience in pharmacology. He was elected to the National Academy of Sciences for his work on immunoassays and sensors for toxins. He has directed a mass spectrometry-based analytical laboratory serving multiple NIH funded projects across the UC Davis campus for 15 years. He is trained in drug metabolism and has worked in metabolomics for many years.
Dr. Hwang obtained his PhD at the University of California, Davis, and is an accomplished medicinal chemist who has extensively worked on inhibitors of soluble epoxide hydrolase and cyclooxygenase. Dr. Hwang is generally interested in the development of small molecule inhibitors as single target and multi-target agents and their pharmacological actions to the regulation of neuroinflammation and neurodegeneration.
My research interest is in the development of analytical tools, methods and bio(medical) technologies that could be applied for monitoring of human health. During my master and PhD training programs, I gained a broad expertise in (micro)engineering, biotechnologies, sensors and Analytical chemistry.
Karen Wagner is an Assistant Research Scientist at the University of California, Davis, with degrees in Pharmacology and Environmental Toxicology. Her research encompasses broader areas of neurobiology and eicosanoid synthesis and metabolism. Current projects are focused on preclinical studies of small molecule enzyme inhibitors and development of rodent cognitive behavioral assays with an emphasis on nociception.
Dr. Yang has over 10 years of experience in analytical chemistry and 9 years of metabolomics experiences, and has been involved in analytical method and data analysis methodology development and the metabolomics and lipidomics platform development. He developed a profiling method for the regulatory lipid mediators including eicosanoids based on LC/MS/MS.